Clinical trials
Myeloproliferative Disorders trials in Switzerland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2005 | 2 |
| 2012 | 1 |
| 2015 | 2 |
| 2017 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Active, not recruiting | 2 |
| Terminated | 2 |
| Recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 4 |
| Incyte Corporation | 2 |
| Ariad Pharmaceuticals | 1 |
| Children's Oncology Group | 1 |
| Cogent Biosciences, Inc. | 1 |
| Novartis Pharmaceuticals | 1 |
| Swiss Cancer Institute | 1 |
| Takeda | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myeloproliferative Disorders | 12 |
| Leukemia | 7 |
| Leukemia, Myelomonocytic, Chronic | 6 |
| Neoplasms | 5 |
| Primary Myelofibrosis | 5 |
| Leukemia, Myeloid, Acute | 4 |
| Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 4 |
| Leukemia, Myeloid, Chronic-Phase | 4 |
| Polycythemia Vera | 4 |
| Thrombocythemia, Essential | 4 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.